Moneycontrol PRO
kiran mazumdar shaw
Jump to
  • Trust Shashi Tharoor to find an error in Kiran Mazumdar-Shaw’s post on ‘amazing’ English sentence May 01, 2022 02:32 PM IST

    Trust Shashi Tharoor to find an error in Kiran Mazumdar-Shaw’s post on ‘amazing’ English sentence

    In her post, Kiran Mazumdar-Shaw shared an example of a rhopalic sentence - and Tharoor spotted an error.

  • 'If IT became communal...': Kiran Mazumdar Shaw flags concern, tags Karnataka Chief Minister Mar 31, 2022 09:24 AM IST

    'If IT became communal...': Kiran Mazumdar Shaw flags concern, tags Karnataka Chief Minister

    Kiran Mazumdar Shaw, tagging Chief Minister Basavaraj Bommai, said if religious divide crept into the IT and biotechnology industry, it would destroy its global leadership.

  • Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow Mar 23, 2022 08:08 PM IST

    Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow

    RSE is one of the world's oldest and most respected academic societies. Fellows are elected to join the RSE from across the fields of science, arts, education, business and public life in recognition of their impact in improving the world around them.

  • Women's Day 2022: 7 business leaders every girl can look up to Mar 08, 2022 09:05 AM IST

    Women's Day 2022: 7 business leaders every girl can look up to

    On International Women's Day 2022, here are a few women who made a mark in business leadership.

  • Biocon acquires Viatris' Biosimilars biz: Kiran Mazumdar-Shaw on deal rationale & growth road map Feb 28, 2022 09:13 PM IST

    Biocon acquires Viatris' Biosimilars biz: Kiran Mazumdar-Shaw on deal rationale & growth road map

    Biocon Biologics, a subsidiary of Biocon, has entered into a definitive agreement with Viatris to acquire the US-based company's biosimilars business in a $3.3 billion stock and cash deal. Catch Nisha Poddar in conversation with Kiran Mazumdar-Shaw to take a deep dive on the deal rationale & growth road map.

  • Biocon's arm to acquire Viatris’ biosimilars for $3.3 billion Feb 28, 2022 07:18 AM IST

    Biocon's arm to acquire Viatris’ biosimilars for $3.3 billion

    Biocon is calling the deal a transformational acquisition creating a world-leading biosimilars enterprise.

  • CNBC-TV18’s 17th IBLA Jury meets; Top Business Leaders present their Vision Board for 2022 Feb 23, 2022 11:25 AM IST

    CNBC-TV18’s 17th IBLA Jury meets; Top Business Leaders present their Vision Board for 2022

    Driving forward the theme ‘Navigating 2022: Chasing the Recovery’, the meeting brought together Global & Indian CEOs to discuss with CNBC-TV18’s Managing Editor, Shereen Bhan, what the year holds amidst the uncertainties brought on by the pandemic

  • Embedding ESG into business strategy Feb 18, 2022 07:37 PM IST

    Embedding ESG into business strategy

    Nisha Poddar delves into the role of ESG in shaping business strategy with corporate leaders, on a special podcast of Ep.3 of PwC India presents 'ESG - A bridge to action'.

  • ‘Spine of Indian business cracks’: India Inc mourns Rahul Bajaj’s death Feb 12, 2022 06:43 PM IST

    ‘Spine of Indian business cracks’: India Inc mourns Rahul Bajaj’s death

    Rahul Bajaj death: Mahindra Group Chairman Anand Mahindra shared a photograph of Rahul Bajaj and thanked him for “cheering” him and “encouraging” him to be “bold”.

  • National Girl Child Day 2022: 7 business leaders every girl can look up to Jan 24, 2022 08:55 AM IST

    National Girl Child Day 2022: 7 business leaders every girl can look up to

    On National Girl Child Day 2022, here are a few women who made a mark in business leadership.

  • Lesser hospitalisations a ‘huge relief’, we need to brace ourselves for variants, Omicron not the last one, says Kiran Mazumdar-Shaw Jan 03, 2022 02:14 PM IST

    Lesser hospitalisations a ‘huge relief’, we need to brace ourselves for variants, Omicron not the last one, says Kiran Mazumdar-Shaw

    The Biocon chief added that added that hospitals are “more prepared this time” and Delta is also not as big a worry as we now know how to deal with it

  • Covid-19 | Imposing lockdowns and travel ban will not stop Omicron: Kiran Mazumdar-Shaw Dec 02, 2021 06:19 PM IST

    Covid-19 | Imposing lockdowns and travel ban will not stop Omicron: Kiran Mazumdar-Shaw

    Biocon Chairperson Kiran Mazumdar-Shaw has said travel bans would not necessarily contain the spread of the new coronavirus strain Omicron, which was identified in South Africa. She also shares the update on the antibody therapy her company is developing with Adagio.

  • COVID-19 | Omicron: Shutting borders will not stop ‘invisible enemy’, need to analyse data, says Kiran Mazumdar-Shaw Dec 02, 2021 09:12 AM IST

    COVID-19 | Omicron: Shutting borders will not stop ‘invisible enemy’, need to analyse data, says Kiran Mazumdar-Shaw

    WHO also said that countries’ travel bans are having an impact on global cooperation against Omicron and causing challenges to sharing of laboratory samples from South Africa that can help get better grips on the new variant

  • Kiran Mazumdar-Shaw says 'Pandora Papers' wrongly implicates husband's offshore trust Oct 04, 2021 12:00 PM IST

    Kiran Mazumdar-Shaw says 'Pandora Papers' wrongly implicates husband's offshore trust

    Millions of leaked documents dubbed as the 'Pandora Papers' by a worldwide journalistic partnership on October 3, claimed to have uncovered financial secrets of current and former world leaders, politicians and public officials in 91 countries and territories, including India.

  • Biocon Biologics, Serum Institute Life Sciences announce strategic alliance Sep 16, 2021 10:05 PM IST

    Biocon Biologics, Serum Institute Life Sciences announce strategic alliance

    Under the alliance, BBL will have access to 100 million doses of vaccines annually for 15 years and commercialisation rights of the SILS vaccine portfolio for global markets.

  • Most VCs in India don’t understand high science, hence don’t invest in bioscience start-ups: Kiran Mazumdar Shaw Sep 15, 2021 07:40 AM IST

    Most VCs in India don’t understand high science, hence don’t invest in bioscience start-ups: Kiran Mazumdar Shaw

    VCs would rather invest in Swiggy or Zomato because that business is easy to understand, says the Executive Chairperson of Biocon and Biocon Biologics. The Biocon Biologics IPO is likely to happen in the year 2023/24, she adds.

  • Tokyo Olympics | Kiran Mazumdar-Shaw mocks posters congratulating boxer Lovlina Borgohain, here is why Aug 03, 2021 01:00 PM IST

    Tokyo Olympics | Kiran Mazumdar-Shaw mocks posters congratulating boxer Lovlina Borgohain, here is why

    The posters did not show a photo of Lovlina Borgohain, but had the faces of Assam Chief Minister Himanta Biswa Sarma and the state's Sports Minister Bimal Borah.

  • Biocon’s Kiran Mazumdar Shaw urges govt to further ease regulations & cut GST to revive economy Jul 16, 2021 03:19 PM IST

    Biocon’s Kiran Mazumdar Shaw urges govt to further ease regulations & cut GST to revive economy

    Biocon’s Executive Chairperson, Kiran Mazumdar Shaw, says we have seen strong and sustainable growth over the last three decades, owing to the bold reforms of the early 90s. However, she adds, the government needs to focus on further easing regulations and administrative requirements to facilitate Ease of Doing Business.

  • Has SEBI erred in the Biocon insider trading case? Jul 13, 2021 10:55 AM IST

    Has SEBI erred in the Biocon insider trading case?

    Insider trading cases are hard to prove but regulators don’t stop trying to stamp out this menace. In Biocon’s case, Sebi’s orders raise vital questions on their soundness.

  • Sebi needs to act rationally in insider trading judgements: Kiran Mazumdar-Shaw Jul 09, 2021 09:08 PM IST

    Sebi needs to act rationally in insider trading judgements: Kiran Mazumdar-Shaw

    Mazumdar-Shaw's tweet came after Sebi barred Allegro Capital and one of its senior executives from the securities market for one year in a case related to alleged insider trading activities in the shares of Biocon.

  • COVID-19 has created an 'ecosystem' of innovation in India: Kiran Mazumdar-Shaw Jun 15, 2021 12:03 PM IST

    COVID-19 has created an 'ecosystem' of innovation in India: Kiran Mazumdar-Shaw

    Kiran Mazumdar-Shaw, 68, is one of the key speakers at the 15th edition of the annual virtual summit on June 22 hosted by the USA India Chambers of Commerce.

  • How Can India Bounce Back After Second Wave? Ask Top CEOs On #MCMasterclass Ep9 Jun 08, 2021 08:06 PM IST

    How Can India Bounce Back After Second Wave? Ask Top CEOs On #MCMasterclass Ep9

    The second wave of the COVID-19 pandemic has derailed India's growth momentum.  How can India march toward its ambitions of becoming a $5 Trillion economy by 2025? What should the Government do to ensure a bounce back and recovery? Will an accelerated vaccination drive help?   Three of India Inc's most respected business leaders and policymakers share their blueprint for recovery on this edition of Moneycontrol Masterclass. Get a chance to ask questions to Kiran Mazumdar-Shaw, KV Kamath, and Manish Sabharwal on June 11th, Friday, 5 pm LIVE. 

  • Biocon chief Kiran Mazumdar-Shaw compares COVID vaccination situation in India to arranged marriage May 15, 2021 06:09 PM IST

    Biocon chief Kiran Mazumdar-Shaw compares COVID vaccination situation in India to arranged marriage

    Earlier this week, Mazumdar-Shaw had expressed concern over shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn.

  • COVID-19 2nd Wave | Kiran Mazumdar-Shaw questions Centre on vaccine production, asks for transparency May 11, 2021 01:00 PM IST

    COVID-19 2nd Wave | Kiran Mazumdar-Shaw questions Centre on vaccine production, asks for transparency

    Kiran Mazumdar-Shaw’s tweet comes as India is embattled in a ferocious second wave of COVID-19, even as the country-wide vaccination drive crawls at a slow pace due to supply shortages.

  • Second wave of COVID19 has hit India 'like a tsunami' says Kiran Mazumdar Shaw May 06, 2021 12:06 PM IST

    Second wave of COVID19 has hit India 'like a tsunami' says Kiran Mazumdar Shaw

    India is struggling with a second wave of the pandemic with more than 3,00,000 daily new coronavirus cases being reported in the past few days, and hospitals are reeling under a shortage of medical oxygen and beds.

Sections
ISO 27001 - BSI Assurance Mark